期刊文献+

联合输注Flt3-L和GM-CSF表达质粒体内诱导小鼠DC的研究 被引量:3

Identification of mouse dentritic cells expanded in vivo by combined over-expression of Flt3-L with GM-CSF
下载PDF
导出
摘要 目的:探讨联合输注Flt3-L和GM-CSF真核表达质粒体内诱导小鼠DC的方法并检测其抗原提呈功能。方法:采用尾静脉注射法分别输注Flt3-L及GM-CSF质粒,15d后收获小鼠脾脏;采用流式细胞术检测小鼠脾细胞CD11c、CD11b、B220、CD8α和NK1.1等表面标志以鉴定DC的比例及亚型;将体内诱导DC与HBsAg共孵育,然后刺激HBsAg预免疫小鼠的脾细胞并检测其分泌IFN-的水平。结果:联合输注Flt3-L和GM-CSF质粒小鼠的脾细胞达到4×108个细胞/脾脏、其中CD11c+细胞占20%以上,CD11c+细胞中CD11b+、CD11b-、B220+、CD8+、NK1.1+细胞的比例分别达17%、10%、26%、16%、7%左右;体内诱导DC负载HB-sAg后刺激HBsAg特异性淋巴细胞分泌IFN-γ的水平明显高于HBsAg单独刺激组。结论:采用小鼠尾静脉注射技术输注Flt3-L及GM-CSF质粒能够诱导CD11c+ DC的产生并包含多种亚型,体内诱导DC具备有效的抗原提呈功能。 AIM:To establish a method to expand dentritic cells (DC) in vivo by combined injection of Flt3-L-expressing plasmid with GM-CSF-expressing plasmid and to analyze their function in antigen presenting. METHODS: Flt3-L and GM-CSF expressing DNAs were injected into the tail veins of BALB/c mice on day 0 and day 10 respectively. The spleens were harvested on day 15 and the splenocytes were prepared to analyze the percentage of CD11c, CD11b, B220, CD8, and NK1.1 positive cells by FACS. The splenocytes from HBsAg-vaccinated mice were stimulated in vitro with DC pre-incubated with HBsAg and then IFN-γ in supernatant after stimulation was detected by ELISA. RESULTS: Combined injection of Flt3-L-expressing plasmid with GM-CSF-expressing plasmid resulted in dramatic splenomegaly in mice. Averagely 4×108 splenocytes were harvested from the expanded spleen of each mouse, more than 20% of which were CD11c+ DC. Among CD11c+ splenocytes, 17% of CD11b+ cells, 10% of CD11b-cells, 26% of B220+ cells, 16% of CD8+ cells and 7% of NK1.1+ cells were detected respectively. When loaded with HBsAg, Flt3-L/GM-GSF DC could stimulate HBsAg-primed splenocytes to secrete much higher IFN-γ than DC or HBsAg alone. CONCLUSION: Combined intravenous injection of Flt3-L-expressing plasmid with GM-CSF-expressing plasmid could in vivo expand dentritic cells which seemed to have many subsets and were able to present antigens to antigen special T cells in vitro.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第6期515-517,521,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30771999 3072783) 江苏省自然科学基金资助项目(BK20082096)
关键词 Flt3-L GM-CSF 真核表达质粒 树突状细胞 体内诱导 小鼠 Flt3-L GM-CSF eukaryotic expression plasmid dentritic cell in vivo mouse
  • 相关文献

参考文献7

  • 1李健,陈元.树突状细胞瘤苗制备及应用的研究进展[J].华中医学杂志,2008,32(1):71-72. 被引量:2
  • 2Onai N, Obata-Onai A, Tussiwand R, et al. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development [ J ]. J Exp Med, 2006, 203 : 227 - 238.
  • 3Masten B J, Olson GK, Kusewitt DF, et al. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice[J]. J Immunol, 2004, 172:4077 -4083.
  • 4Swanson KA, Zheng Y, Heidler KM. Flt3-Ligand, IL-4, GM-CSF, and adherence-mediated isolation of murine lung dendritic ceils: Assessment of isolation technique on phenotype and function - J Immunol, 2004, 172: 1762.
  • 5Yo YT, Hsu KF, Shieh GS, et al. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine [ J]. Cancer Gene Therapy, 2007, 14 : 904 - 917.
  • 6del Hoyo M, Martin P, Arias CF, et al. CD8α + dendritic cells originate from the CD8α- dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation[ J]. Blood, 2002, 99:999 - 1004.
  • 7Matsumura N, Mandai M, Hamanishi J, et al. Immuncostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer ceils: Utilization for ovarian cancer treatment [ J]. Oncology Reports, 2008, 19 : 505 - 515.

二级参考文献12

  • 1Barbuto JA, Ensina LF, Neves AR et al. Dendritic celltumor cell hybrid vaccination for metastatic cancer. Cancer Immunol Immunother, 2004,53 (12) : 1111
  • 2Wilson N, Mikol C,Donaldson A et al. Dendritic cell immunotherapy for advanced metastatic melanoma, interim report. Journal of Immunotherapy, 20(15,28(6) : 661
  • 3Yu John SMD,Liu Gentao PhD,Ng Hiushan MS et al. A phase I trial of intracranial dendritic cell irnmunotherapy for patients with malignant glioma. 894. Neurosurgery, 2006,59(2):485
  • 4Sauma D, Michea P, Lennon-Dumenil AM et al. Interleukin-4 selectively inhibits interleukin-2 secretion by lipopolysaccaride-activated dendritic cells, scandinavian journal of immunology,2004,59(2) : 183
  • 5Kalady MF,Onaitis MW, Emani Set al. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity, Surg Res, 2004,116 (1) : 24
  • 6Gao N, Flynn DC, Zhang Z et al. G1 cell cycle progression and the expression of G1 cyclins are regulated byPI3K/ AKT/mTOR/pTOS6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol,2004,287(2) : 281
  • 7Xu G, Zhang WH, Bertram Pet al. Pharmacogenornic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors. Int J Oncol,2004,24(9):893
  • 8Yoshiura K, Nakaoka T, Nishishita T et al. Carbonic anhydrase Ⅱ is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res, 2005,11 (22) :8201
  • 9Mayordomo JI,Andres R,Isla MD et al. Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer. Tumori,2007,93(1) :26
  • 10Adam C, Mysliwietz J, Mocikat R. Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine. J Transl Med, 2007,5 ( 1 ): 16

共引文献1

同被引文献37

  • 1陈剑群,吴克俭,费素娟,金玉,刘同珞.榄香烯注射液对恶性肿瘤患者外周血T淋巴细胞亚群的影响[J].中国肿瘤临床,1996,23(4):299-301. 被引量:36
  • 2Kang Sun,Liang Wang,Yanyun Zhang.Dendritic Cell as Therapeutic Vaccines against Tumors and Its Role in Therapy for Hepatocellular Carcinoma[J].Cellular & Molecular Immunology,2006,3(3):197-203. 被引量:22
  • 3秦叔逵,钱军,杨爱珍,王琳,乐美兆,何泽明,刘文虎.榄香烯乳抗肺癌细胞的实验研究[J].肿瘤防治研究,1996,23(4):251-255. 被引量:38
  • 4Yuhuan Li, Li-Xin Wang, Guojun Yang, et al. Efficient cross- presentation depends on autophagy in tumor cells[ J ] .Cancer Res ,2008,68 ( 17 ): 6889-6895.
  • 5Masten BJ, Olson GK, Kusewilt DF, el al. Fh3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice[ J ] . Immunol, 2004, 172 : 4077-4083.
  • 6Shoaman K, Heath WR. The CD8: dendritic cell subset[J]. Immtmol Rev, 2010, 234(1) : 18 -31.
  • 7Poulin LF, Salio M, Griessinger E, et al. Characterization of human DNGR-1 + BDCA3 + leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells[J]. J Exp Med, 2010 , 207(6) : 1261 - 1271.
  • 8Crozat K, Guiton R, Contreras V, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8ct+ dendritic cells[J]. J Exp Med, 2010, 207(6) : 1283 - 1292.
  • 9Toubai T, Malter C, Tawara I, et al. Immunization with host-type CD8ct + dendritic cells reduces experimental acute GVHD in an IL-10- dependent manner[J]. Blood, 2010, 115(3): 724-735.
  • 10Farrand KJ, Diekgreber N, Stoitzner P, et al. Langerin+ CD8ct: dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens[ J]. J Immunol, 2009, 183 (12) : 7732 - 7742.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部